Methotrexate (methotrexate): Reviews and patient testimonials
Back to the list of medications
Medication indications
Methotrexate 10 mg Tablets
• Severe forms of psoriasis vulgaris, particularly of the plaque type, which cannot be sufficiently treated with conventional therapy such as phototherapy and PUVA, and severe psoriatic arthritis.• Active rheumatoid arthritis in adult patients.Methotrexate 100 mg/ml concentrate for solution for infusion
Acute lymphocytic leukaemia, Non-Hodgkin's lymphomas, osteogenic sarcoma, adjuvant and in advance disease of breast cancer, metastatic or recurrent head and neck cancer, choriocarcinoma and similar trophoblastic diseases, advanced cancer of urinary bladder.Methotrexate 100 mg/ml Injection
Methotrexate is indicated in the treatment of neoplastic disease, such as trophoblastic neoplasms and leukaemia, and the symptomatic treatment of severe recalcitrant disabling psoriasis which is not adequately responsive to other forms of therapy.
Methotrexate 100 mg/ml solution for injection
Methotrexate 100 mg/ml solution for injection may be used for the following indications:
• Acute lymphocytic leukaemias (ALL)
- in combination with other cytotoxic medicinal products
• Non-Hodgkin's lymphomas
- in combination with other cytotoxic medicinal products in adult patients with Non-Hodgkin's lymphomas of intermediate and high degree of malignancy
- -in combination with other cytotoxic medicinal products in paediatric patients
• Head and neck cancer
- as palliative monotherapy in patients with metastatic or recurrent disease
• Breast cancer
- in combination with other cytotoxic medicinal products in patients for adjuvant treatment after tumour resection or mastectomy and for palliative treatment in advanced disease
• Choriocarcinoma and similar trophoblastic diseases
- as monotherapy in patients with good prognosis (low risk)
- in combination with other cytotoxic medicinal products in patients with poor prognosis (high risk)
• Osteosarcoma
- in combination with other cytotoxic medicinal products for adjuvant and neoadjuvant therapy
• Cancer of the bladder
- in combination with other cytotoxic medicinal products
Methotrexate 10mg tablets
- Active rheumatoid arthritis in adult patients.- Severe recalcitrant disabling psoriasis, which is not adequately responsive to other forms of therapy such as phototherapy, PUVA, and retinoids, and severe psoriatic arthritis in adult patientsMethotrexate 10mg Tablets BP
The treatment of acute lymphoblastic leukaemia and Burkitt's lymphoma. The treatment of severe cases of uncontrolled psoriasis, unresponsive to conventional therapy.
Methotrexate 2.5 mg Tablets
• Severe forms of psoriasis vulgaris, particularly of the plaque type, which cannot be sufficiently treated with conventional therapy such as phototherapy and PUVA, and severe psoriatic arthritis.
• Active rheumatoid arthritis in adult patients.
Methotrexate 2.5 mg/ml Injection
Methotrexate is indicated in the treatment of neoplastic disease, such as trophoblastic neoplasms and leukaemia, and the symptomatic treatment of severe recalcitrant disabling psoriasis which is not adequately responsive to other forms of therapy.
Methotrexate 2.5mg Tablets
Methotrexate is a folic acid antagonist and is classified as an antimetabolite cytotoxic agent.
Methotrexate has been used to produce regression in a wide range of neoplastic conditions including acute leukaemias, non-Hodgkin's lymphoma, soft-tissue and osteogenic sarcomas, and solid tumours particularly breast, lung, head and neck, bladder, cervical, ovarian, and testicular carcinoma.
The treatment of neoplastic disease. Methotrexate has also been used in the treatment of severe cases of uncontrolled psoriasis, unresponsive to conventional therapy.
It is also used in the treatment of adults with severe, active, classical or definite rheumatoid arthritis who are unresponsive or intolerant to conventional therapy.
Methotrexate 2.5mg tablets
- Active rheumatoid arthritis in adult patients. - Severe recalcitrant disabling psoriasis, which is not adequately responsive to other forms of therapy such as phototherapy, PUVA, and retinoids, and severe psoriatic arthritis in adult patientsMethotrexate 2.5mg Tablets BP
The treatment of acute lymphoblastic leukaemia and Burkitt's lymphoma. The treatment of severe cases of uncontrolled psoriasis, unresponsive to conventional therapy.
The treatment of adults with severe, active, classical or definite rheumatoid arthritis who are unresponsive or intolerant to conventional therapy.
Methotrexate 25 mg/ml Injection
Methotrexate is indicated in the treatment of neoplastic disease, such as trophoblastic neoplasms and leukaemia, and the symptomatic treatment of severe recalcitrant disabling psoriasis which is not adequately responsive to other forms of therapy.
Methotrexate 25 mg/ml solution for injection
Acute lymphocytic leukaemia, prophylaxis of meningeal leukaemia, Non-Hodgkin's lymphomas, osteogenic sarcoma, adjuvant and in advance disease of breast cancer, metastatic or recurrent head and neck cancer, choriocarcinoma and similar trophoblastic diseases, advanced cancer of urinary bladder.Methotrexate 25 mg/ml solution for injection, pre-filled syringe
- Active rheumatoid arthritis in adult patients where treatment with disease modifying antirheumatic drugs (DMARD) is indicated. - Polyarthritic forms of severe, active juvenile idiopathic arthritis (JIA), when the response to non-steroidal anti-inflammatory drugs (NSAIDs) has been inadequate.- Severe forms of psoriasis vulgaris, particularly of the plaque type, which cannot be sufficiently treated with conventional therapy such as phototherapy, PUVA, and retinoids, and severe psoriatic arthritis.Methotrexate 2mg/ml Oral Solution
Methotrexate 2mg/ml Oral Solution is indicated in the following oncological indications:• The maintenance treatment of Acute Lymphocytic Leukaemia (ALL) in children and adults.• The treatment of malignant trophoblastic tumoursMethotrexate 2mg/ml Oral Solution is indicated in:• The treatment of severe active rheumatoid arthritis in adults.• The treatment of severe forms of psoriasis vulgaris including chronic plaque psoriasis, erythrodermic psoriasis, psoriatic arthritis and pustular psoriasis which are not responsive to other conventional therapies such as phototherapy, PUVA and retinoids.Route of administration: Injectable, Oral
Molecule: methotrexate
Tips and advice of the community